Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BridgeBio Oncology Therapeutics, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BridgeBio Oncology Therapeutics, Inc.Listing unverified | Other | $1.1K | SEC | ||
BridgeBio Oncology Therapeutics, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
BridgeBio Oncology Therapeutics, Inc.Listing unverified | Other | $975 | SEC | ||
Tricida, Inc.Listing unverified | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Tricida, Inc.Listing unverified | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |